MedTrace Logo

Clinical Characteristics, Lifestyle and Multi-omics Analysis in Autoimmune Gastritis

NCT05820607 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2023-04-19

No results posted yet for this study

Summary

This research will be conducted nationwide in patients with autoimmune gastritis, focusing on their clinical characteristics, possible risk factors, and multi-omics analysis. Changes in gastrointestinal microbiota, host and microbial metabolism, gene transcription and biomarkers of autoimmune gastritis will be explored to provide evidence for further precise therapy of the disease.

Conditions

  • Autoimmune Gastritis

Interventions

BIOLOGICAL

Microbiome, metabolome, transcriptome, genome

Fecal genome, serum metabolome, leukocyte transcriptome, gastric mucosa genome

Sponsors & Collaborators

  • Shanghai Tong Ren Hospital

    collaborator OTHER

  • Seventh Medical Center of PLA Army General Hospital

    collaborator OTHER

  • Tianjin Medical University General Hospital

    collaborator OTHER

  • The Affiliated Hospital of Qingdao University

    collaborator OTHER

  • Southern Medical University, China

    collaborator OTHER

  • The First Affiliated Hospital of Nanchang University

    collaborator OTHER

  • Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Jingyuan Fang, MD, Ph.D · Shanghai Institute of Digestive Disease

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-19
Primary Completion
2023-07-31
Completion
2024-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05820607 on ClinicalTrials.gov